List of bibliographic references
Number of relevant bibliographic references: 667.
[0-20] [
0 - 20][
0 - 50][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000017 (1999) |
S S Mirra [États-Unis] ; J R Murrell ; M. Gearing ; M G Spillantini ; M. Goedert ; R A Crowther ; A I Levey ; R. Jones ; J. Green ; J M Shoffner ; B H Wainer ; M L Schmidt ; J Q Trojanowski ; B. Ghetti | Tau pathology in a family with dementia and a P301L mutation in tau. |
| 000018 (1999) |
G W Parkinson [États-Unis] ; K E Gordon ; C S Camfield ; E A Fitzpatrick | Anxiety in parents of young febrile children in a pediatric emergency department: why is it elevated? |
| 000021 (1999) |
J A Barone [États-Unis] | Domperidone: a peripherally acting dopamine2-receptor antagonist. |
| 000100 (2000) |
M. Aschner [États-Unis] | Manganese: brain transport and emerging research needs. |
| 000139 (2000) |
P. Watkins [États-Unis] | COMT inhibitors and liver toxicity. |
| 000162 (2001) |
J E Ahlskog [États-Unis] ; M D Muenter | Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. |
| 000365 (2003) |
Patrice D. Smith [Canada] ; Stephen J. Crocker [Canada] ; Vernice Jackson-Lewis ; Kelly L. Jordan-Sciutto [États-Unis] ; Shawn Hayley [Canada] ; Matthew P. Mount [Canada] ; Michael J. O'Hare [Canada] ; Steven Callaghan [Canada] ; Ruth S. Slack [Canada] ; Serge Przedborski [États-Unis] ; Hymie Anisman [Canada] ; David S. Park [Canada] | Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease |
| 000371 (2003) |
Paul Alan Cox [États-Unis] ; Sandra Anne Banack ; Susan J. Murch | Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam. |
| 000417 (2004) |
Cynthia Mcrae [États-Unis] ; Eva Cherin ; T Gayle Yamazaki ; Gretchen Diem ; Alexander H. Vo ; Dan Russell ; J Heiner Ellgring ; Stanley Fahn ; Paul Greene ; Sandra Dillon ; Hal Winfield ; Kimberly B. Bjugstad ; Curt R. Freed | Effects of perceived treatment on quality of life and medical outcomes in a double-blind placebo surgery trial. |
| 000440 (2004) |
Jh Lee [États-Unis] ; R. Mayeux [États-Unis] ; D. Mayo [États-Unis] ; J. Mo [États-Unis] ; V. Santana [États-Unis] ; J. Williamson [États-Unis] ; A. Flaquer [États-Unis] ; A. Ciappa [États-Unis] ; H. Rondon [États-Unis, République dominicaine] ; P. Estevez [États-Unis] ; R. Lantigua [États-Unis] ; T. Kawarai [Canada] ; A. Toulina [Canada] ; M. Medrano [République dominicaine] ; M. Torres [République dominicaine] ; Y. Stern [États-Unis] ; B. Tycko [États-Unis] ; E. Rogaeva [Canada] ; P St. George-Hyslop [Canada] ; Ja Knowles [États-Unis] | Fine mapping of 10q and 18q for familial Alzheimer’s disease in Caribbean Hispanics |
| 000444 (2004) |
Robert G. Holloway [États-Unis] ; Ira Shoulson ; Stanley Fahn ; Karl Kieburtz ; Anthony Lang ; Kenneth Marek ; Michael Mcdermott ; John Seibyl ; William Weiner ; Bruno Musch ; Cornelia Kamp ; Mickie Welsh ; Aileen Shinaman ; Rajesh Pahwa ; Lynn Barclay ; Jean Hubble ; Peter Lewitt ; Janis Miyasaki ; Oksana Suchowersky ; Mark Stacy ; David S. Russell ; Blair Ford ; John Hammerstad ; David Riley ; David Standaert ; Frederick Wooten ; Stewart Factor ; Joseph Jankovic [États-Unis] ; Farah Atassi ; Roger Kurlan ; Michel Panisset ; Ali Rajput ; Robert Rodnitzky ; Cliff Shults ; Giselle Petsinger ; Cheryl Waters ; Ronald Pfeiffer ; Kevin Biglan ; Leona Borchert ; Amy Montgomery ; Laura Sutherland ; Carolyn Weeks ; Maryan Deangelis ; Elspeth Sime ; Susan Wood ; Carol Pantella ; Mary Harrigan ; Barbara Fussell ; Sandra Dillon ; Barbara Alexander-Brown ; Pamela Rainey ; Marsha Tennis ; Elke Rost-Ruffner ; Diane Brown ; Sharon Evans ; Debra Berry ; Jean Hall ; Theresa Shirley ; Judith Dobson ; Deborah Fontaine ; Brenda Pfeiffer ; Alicia Brocht ; Susan Bennett ; Susan Daigneault ; Karen Hodgeman ; Carolynn O'Connell ; Tori Ross ; Karen Richard ; Arthur Watts | Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. |
| 000446 (2004) |
Kimberley A. Walsh [Canada] ; Joseph F. Megyesi [Canada] ; John X. Wilson [Canada] ; Jeff Crukley [Canada] ; Victor E. Laubach [États-Unis] ; Robert R. Hammond [Canada] | Antioxidant protection from HIV-1 gp120-induced neuroglial toxicity |
| 000537 (2005) |
Ivar Mendez ; Rosario Sanchez-Pernaute [États-Unis] ; Oliver Cooper [États-Unis] ; Angel Vi Uela [États-Unis] ; Daniela Ferrari [États-Unis] ; Lars Björklund [États-Unis] ; Alain Dagher [Canada] ; Ole Isacson [États-Unis] | Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson’s disease |
| 000564 (2005) |
Dan Frenkel [États-Unis] ; Ruth Maron [États-Unis] ; David S. Burt [Canada] ; Howard L. Weiner [États-Unis] | Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears
β-amyloid in a mouse model
of Alzheimer disease |
| 000568 (2005) |
Nicoletta Pedemonte [États-Unis, Italie] ; Gergely L. Lukacs [Canada] ; Kai Du [Canada] ; Emanuela Caci [Italie] ; Olga Zegarra-Moran [Italie] ; Luis J. V. Galietta [Italie] ; A. S. Verkman [États-Unis] | Small-molecule correctors of defective
ΔF508-CFTR cellular processing identified
by high-throughput screening |
| 000575 (2005) |
Thomas J. Montine [États-Unis] ; Ke Li ; Daniel P. Perl ; Douglas Galasko | Lack of beta-methylamino-l-alanine in brain from controls, AD, or Chamorros with PDC. |
| 000580 (2005) |
William G. Ondo [États-Unis] ; Helen Bronte-Stewart | The North American survey of placement and adjustment strategies for deep brain stimulation. |
| 000584 (2005) |
Stanley Fahn [États-Unis] | Does levodopa slow or hasten the rate of progression of Parkinson's disease? |
| 000591 (2005) |
Wonsuk Yang [États-Unis] ; Evelyn Tiffany-Castiglioni | The bipyridyl herbicide paraquat produces oxidative stress-mediated toxicity in human neuroblastoma SH-SY5Y cells: relevance to the dopaminergic pathogenesis. |
| 000605 (2005) |
William J. Weiner [États-Unis] | Research update on Parkinson's disease and other movement disorders: highlights from the Eighteenth Annual Symposium on the Etiology, Pathogenesis, and Treatment of Parkinson's Disease and Other Movement Disorders, October 3, 2004, Toronto, Ontario, Canada. |
| 000619 (2006) |
Karen Blindauer [États-Unis] ; Ira Shoulson ; David Oakes ; Karl Kieburtz ; Steven Schwid ; Stanley Fahn ; Matthew Stern ; Christopher Goetz ; John Nutt ; Sari Goren ; Naim Sayag ; Marisa Scolnik ; Ruth Levy ; Eli Eyal ; Phyllis Salzman ; Mary Pagano | A randomized controlled trial of etilevodopa in patients with Parkinson disease who have motor fluctuations. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/AffPays.i -k "États-Unis"
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/AffPays.i \
-Sk "États-Unis" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Ncbi
|étape= Checkpoint
|type= indexItem
|index= AffPays.i
|clé= États-Unis
}}
| This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022 |  |
